Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription Articles published in Radiology Retrieve available abstracts of 174 articles: HTML format

Single Articles

April 2024
1. YOON JH, Kim YK, Kim JW, Chang W, et al
   Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI.
   Radiology. 2024;311:e233114.
   PubMed     Abstract available
   
   
   
2. LEE Y, Kim NH, Kang JH, Cho YS, et al
   Validation of Diagnostic Thresholds for Compensated Advanced Chronic Liver Disease Using Supersonic Shear Imaging.
   Radiology. 2024;311:e232188.
   PubMed     Abstract available
   
   
   March 2024
3. MOURA CUNHA G, Fan B, Navin PJ, Olivie D, et al
   Interpretation, Reporting, and Clinical Applications of Liver MR Elastography.
   Radiology. 2024;310:e231220.
   PubMed     Abstract available
   
   
   
4. LIU F, Bi M, Jing X, Ding H, et al
   Multiparametric US for Identifying Metabolic Dysfunction-associated Steatohepatitis: A Prospective Multicenter Study.
   Radiology. 2024;310:e232416.
   PubMed     Abstract available
   
   
   
5. REUTER KL
   Noninvasive Identification of Metabolic Dysfunction-associated Steatohepatitis Globally.
   Radiology. 2024;310:e240436.
   PubMed    
   
   
   February 2024
6. CHAPIRO J
   Image-guided High-Dose-Rate Brachytherapy for Hepatocellular Carcinoma Could Be the Ultimate Ablation Tool.
   Radiology. 2024;310:e240072.
   PubMed    
   
   
   
7. AUER TA, Muller L, Schulze D, Anhamm M, et al
   CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma.
   Radiology. 2024;310:e232044.
   PubMed     Abstract available
   
   
   
8. SHEWAREGA A, Santana JG, Nam D, Berz A, et al
   Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8(+) T-Cell Infiltration in Murine Hepatocellular Carcinoma.
   Radiology. 2024;310:e232365.
   PubMed     Abstract available
   
   
   
9. GEMMETE JJ
   Partial Cryoablation and Matrix Metalloproteinase Inhibition May Be a Possible Treatment Option for Hepatocellular Carcinoma.
   Radiology. 2024;310:e240015.
   PubMed    
   
   
   
10. CRIVELLARO P
    A Deeper Look into Ancillary Features in LI-RADS Classification.
    Radiology. 2024;310:e240251.
    PubMed    
    
    
    
11. DAWIT H, Lam E, McInnes MDF, van der Pol CB, et al
    LI-RADS CT and MRI Ancillary Feature Association with Hepatocellular Carcinoma and Malignancy: An Individual Participant Data Meta-Analysis.
    Radiology. 2024;310:e231501.
    PubMed     Abstract available
    
    
    
12. CANNELLA R, Matteini F, Dioguardi Burgio M, Sartoris R, et al
    Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
    Radiology. 2024;310:e231160.
    PubMed     Abstract available
    
    
    
13. KARTALIS N, Grigoriadis A
    LI-RADS in Patients with Solitary Resected Hepatocellular Carcinoma: Glancing beyond Diagnosis.
    Radiology. 2024;310:e240161.
    PubMed    
    
    
    January 2024
14. MA L, Zhang W, Ma J, Luo J, et al
    Transjugular Intrahepatic Portosystemic Shunt versus Endoscopy with Drug Therapy Warrants Further Exploration.
    Radiology. 2024;310:e232499.
    PubMed    
    
    
    
15. TAN XZ, Chen X, Liu P
    Potential Influence of Inconsistent Arterial Phase Imaging on Macrotrabecular-massive Hepatocellular Carcinoma Prediction.
    Radiology. 2024;310:e232349.
    PubMed    
    
    
    
16. KADI D, Loomba R, Bashir MR
    Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions.
    Radiology. 2024;310:e222695.
    PubMed     Abstract available
    
    
    
17. FOWLER KJ, Chernyak V
    What Is in a Name: Understanding the Nomenclature Updates for Fatty Liver Disease.
    Radiology. 2024;310:e232771.
    PubMed    
    
    
    
18. DIETRICH CF
    Modified Algorithm for Contrast-enhanced US LI-RADS.
    Radiology. 2024;310:e232742.
    PubMed    
    
    
    December 2023
19. GOINS SM, Jiang H, van der Pol CB, Salameh JP, et al
    Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis.
    Radiology. 2023;309:e231656.
    PubMed     Abstract available
    
    
    
20. SIRLIN CB, Chernyak V
    Are We Ready to Simplify and Improve LI-RADS?
    Radiology. 2023;309:e233164.
    PubMed    
    
    
    
21. TAMIR S, Tau N
    Hepatocellular Carcinoma and Pretransplant Liver Imaging: Benefits of Per-patient Assessment.
    Radiology. 2023;309:e233123.
    PubMed    
    
    
    
22. HASSAN OT, Behr SC, Ohliger MA, Fowler KJ, et al
    Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.
    Radiology. 2023;309:e222776.
    PubMed     Abstract available
    
    
    November 2023
23. JIANG H, Yang C, Chen Y, Wang Y, et al
    Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
    Radiology. 2023;309:e230527.
    PubMed     Abstract available
    
    
    
24. HSIEH C, Laguna A, Ikeda I, Maxwell AWP, et al
    Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.
    Radiology. 2023;309:e222891.
    PubMed     Abstract available
    
    
    
25. TSAI R, Mellnick VM
    Using an Imaging Model to Predict Recurrence in Patients with Hepatocellular Carcinoma.
    Radiology. 2023;309:e232480.
    PubMed    
    
    
    
26. OZTURK A, Kumar V, Pierce TT, Li Q, et al
    The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease.
    Radiology. 2023;309:e223146.
    PubMed     Abstract available
    
    
    
27. TAN XZ, Liu P, Xiang H
    The Influence of Single Arterial Phase Imaging on Prediction of Microvascular Invasion of Hepatocellular Carcinoma.
    Radiology. 2023;309:e231141.
    PubMed    
    
    
    October 2023
28. TUTHILL TA
    Advancing AI-assisted US Screening for Fatty Liver.
    Radiology. 2023;309:e232442.
    PubMed    
    
    
    
29. HAN A
    Hepatic Steatosis Assessment: Harnessing the Power of Integrating Multiple Quantitative US Parameters.
    Radiology. 2023;309:e232475.
    PubMed    
    
    
    
30. VIANNA P, Calce SI, Boustros P, Larocque-Rigney C, et al
    Comparison of Radiologists and Deep Learning for US Grading of Hepatic Steatosis.
    Radiology. 2023;309:e230659.
    PubMed     Abstract available
    
    
    
31. KURODA H, Oguri T, Kamiyama N, Toyoda H, et al
    Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
    Radiology. 2023;309:e230341.
    PubMed     Abstract available
    
    
    
32. SAVSANI E, Shaw CM, Forsberg F, Wessner CE, et al
    Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial.
    Radiology. 2023;309:e230727.
    PubMed     Abstract available
    
    
    
33. HEO S, Lee SS, Choi SH, Kim DW, et al
    CT Rule-in and Rule-out Criteria for Clinically Significant Portal Hypertension in Chronic Liver Disease.
    Radiology. 2023;309:e231208.
    PubMed     Abstract available
    
    
    
34. FRAUM TJ
    CT-based Diagnosis of Clinically Significant Portal Hypertension: An Opportunity to Prevent Complications.
    Radiology. 2023;309:e232439.
    PubMed    
    
    
    
35. XIA T, Du M, Li H, Wang Y, et al
    Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk.
    Radiology. 2023;309:e231007.
    PubMed     Abstract available
    
    
    
36. REEDER SB, Starekova J
    MRI Proton Density Fat Fraction for Liver Disease Risk Assessment: A Call for Clinical Implementation.
    Radiology. 2023;309:e232552.
    PubMed    
    
    
    
37. MONSELL SE
    Statistical Methods for Exploring Causal Relationships between Risk Factors and Liver Disease.
    Radiology. 2023;309:e232551.
    PubMed    
    
    
    
38. FOWLER KJ, Venkatesh SK, Obuchowski N, Middleton MS, et al
    Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.
    Radiology. 2023;309:e231092.
    PubMed     Abstract available
    
    
    
39. KOZAKA K, Matsui O
    MRI Biomarkers and Their Future Impact on Nonalcoholic Fatty Liver Disease.
    Radiology. 2023;309:e232420.
    PubMed    
    
    
    September 2023
40. HYODO R, Takehara Y, Mizuno T, Ichikawa K, et al
    Four-dimensional Flow MRI Assessment of Portal Hemodynamics and Hepatic Regeneration after Portal Vein Embolization.
    Radiology. 2023;308:e230709.
    PubMed     Abstract available
    
    
    August 2023
41. LI X, Zhang Y, Wang X, Zeng H, et al
    Predicting Infectious Complications after Percutaneous Thermal Ablation of Liver Malignancies: A 12-year Single-Center Experience.
    Radiology. 2023;308:e223091.
    PubMed     Abstract available
    
    
    
42. BEN-ARIE G, Sosna J
    Predicting Infectious Complications after US-guided Ablation of Liver Malignancies: Personalized Patient Care.
    Radiology. 2023;308:e231681.
    PubMed    
    
    
    
43. LI J, Liu G, Xie X, Zhang D, et al
    Outcomes Following Different Thermal Ablation Strategies in Patients with Unresectable Colorectal Liver Metastases.
    Radiology. 2023;308:e223135.
    PubMed     Abstract available
    
    
    
44. GEORGIADES CS
    Combination Systemic Chemotherapy and Ablation Treatment for Potentially Curable Patients with Colorectal Liver Metastases: Ablate Completely and Ablate Early.
    Radiology. 2023;308:e231709.
    PubMed    
    
    
    
45. LI M, Fan Y, You H, Li C, et al
    Dual-Energy CT Deep Learning Radiomics to Predict Macrotrabecular-Massive Hepatocellular Carcinoma.
    Radiology. 2023;308:e230255.
    PubMed     Abstract available
    
    
    
46. WANG X, Liu G, Wu J, Xiao X, et al
    Small-Diameter Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation Plus Propranolol for Variceal Rebleeding in Advanced Cirrhosis.
    Radiology. 2023;308:e223201.
    PubMed     Abstract available
    
    
    
47. CHU LC, Fishman EK
    AI as Virtual Biopsy Tool to Predict Macrotrabecular-Massive Hepatocellular Carcinoma.
    Radiology. 2023;308:e231663.
    PubMed    
    
    
    
48. BARTH KH
    Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation, an Unequal Competition.
    Radiology. 2023;308:e231774.
    PubMed    
    
    
    
49. LI L, Zou X, Zheng W, Li Y, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane: LI-RADS for Diagnosing Hepatocellular Carcinoma.
    Radiology. 2023;308:e230150.
    PubMed     Abstract available
    
    
    
50. BAO Y, Li JX, Zhou P, Tong Y, et al
    Identifying Proliferative Hepatocellular Carcinoma at Pretreatment CT: Implications for Therapeutic Outcomes after Transarterial Chemoembolization.
    Radiology. 2023;308:e230457.
    PubMed     Abstract available
    
    
    
51. KIM TK
    Contrast-enhanced US Incorporating Kupffer-Phase Findings for the Diagnosis of Hepatocellular Carcinoma.
    Radiology. 2023;308:e231494.
    PubMed    
    
    
    July 2023
52. WANG C, Huang Y, Liu C, Liu F, et al
    Erratum for: Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.
    Radiology. 2023;308:e239019.
    PubMed    
    
    
    June 2023
53. BARR RG, Scoutt LM
    Screening for Hepatocellular Carcinoma:Image Quality Is Everything!
    Radiology. 2023;307:e231089.
    PubMed    
    
    
    
54. PARK MK, Lee DH, Hur BY, Lee HC, et al
    Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
    Radiology. 2023;307:e222106.
    PubMed     Abstract available
    
    
    
55. HONG CW, Chernyak V, Choi JY, Lee S, et al
    A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT.
    Radiology. 2023;307:e222855.
    PubMed     Abstract available
    
    
    
56. JOHNSON SA
    Reliability of LI-RADS for MRI and CT: Is Excellence Achievable?
    Radiology. 2023;307:e231066.
    PubMed    
    
    
    
57. GALGANO SJ, Smith EN
    LI-RADS Version 2018 for MRI and CT: Interreader Agreement in Real-World Practice.
    Radiology. 2023;307:e231212.
    PubMed    
    
    
    May 2023
58. PENG D, Cao J, Guo C, He J, et al
    Influence of Cirrhosis on (68)Ga-FAPI PET/CT in Intrahepatic Tumors.
    Radiology. 2023 May 23:222448. doi: 10.1148/radiol.222448.
    PubMed     Abstract available
    
    
    
59. NACHIT M, Horsmans Y, Summers RM, Leclercq IA, et al
    AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
    Radiology. 2023 May 16:222008. doi: 10.1148/radiol.222008.
    PubMed     Abstract available
    
    
    
60. GOINS SM, Adamo RG, Lam E, Costa AF, et al
    Conversion Strategy for LI-RADS Category 5 Observations across Versions 2014, 2017, and 2018.
    Radiology. 2023;307:e222971.
    PubMed    
    
    
    April 2023
61. XIA TY, Zhou ZH, Meng XP, Zha JH, et al
    Predicting Microvascular Invasion in Hepatocellular Carcinoma Using CT-based Radiomics Model.
    Radiology. 2023 Apr 25:222729. doi: 10.1148/radiol.222729.
    PubMed     Abstract available
    
    
    
62. SUMMERS RM
    Radiomics to Predict Microvascular Invasion in Hepatocellular Carcinoma: A Promising Biomarker for Tumor Recurrence.
    Radiology. 2023 Apr 25:230657. doi: 10.1148/radiol.230657.
    PubMed    
    
    
    
63. FOWLER KJ, Chernyak V, Ronot M, Vilgrain V, et al
    Hepatocellular Carcinoma: It Is Time to Focus on Prognosis.
    Radiology. 2023 Apr 4:220884. doi: 10.1148/radiol.220884.
    PubMed    
    
    
    
64. RONOT M, Chernyak V, Burgoyne A, Chang J, et al
    Imaging to Predict Prognosis in Hepatocellular Carcinoma: Current and Future Perspectives.
    Radiology. 2023 Apr 4:221429. doi: 10.1148/radiol.221429.
    PubMed     Abstract available
    
    
    
65. CHERNYAK V, Fowler KJ, Do RKG, Kamaya A, et al
    LI-RADS: Looking Back, Looking Forward.
    Radiology. 2023;307:e222801.
    PubMed     Abstract available
    
    
    
66. FERRAIOLI G, Barr RG
    Interpreting Liver Stiffness Values in Clinical Practice: Is Histologic Classification Necessary for Clinical Relevance?
    Radiology. 2023;307:e220553.
    PubMed    
    
    
    
67. VAN DER POL CB, McInnes MDF, Salameh JP, Levis B, et al
    CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    Radiology. 2023;307:e239005.
    PubMed    
    
    
    March 2023
68. GRANT EG
    Calibrated US for Quantification of Fatty Liver Disease.
    Radiology. 2023;306:e221540.
    PubMed    
    
    
    
69. SUGIMOTO K, Lee DH, Itoi T
    Response to "Limitations of a Multiparametric US Score for NASH Prediction".
    Radiology. 2023;306:e221498.
    PubMed    
    
    
    February 2023
70. YEOM A, Chi SA, Song KD
    Added Value of Pelvic CT after Treatment of HCC.
    Radiology. 2023 Feb 21:222314. doi: 10.1148/radiol.222314.
    PubMed     Abstract available
    
    
    
71. JIANG H, Wei H, Yang T, Qin Y, et al
    VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC.
    Radiology. 2023 Feb 14:221835. doi: 10.1148/radiol.221835.
    PubMed     Abstract available
    
    
    
72. HARMATH CB
    Beyond LI-RADS: Decoding the Prognostic Value of MRI Findings in HCC.
    Radiology. 2023 Feb 14:223309. doi: 10.1148/radiol.223309.
    PubMed    
    
    
    January 2023
73. ROLDAN-ALZATE A, Reeder SB
    Image-based Vascular Modeling for Portal Hypertension Diagnosis.
    Radiology. 2023 Jan 31:223163. doi: 10.1148/radiol.223163.
    PubMed    
    
    
    
74. WANG C, Huang Y, Liu C, Liu F, et al
    Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.
    Radiology. 2023 Jan 31:221648. doi: 10.1148/radiol.221648.
    PubMed     Abstract available
    
    
    
75. SOFOCLEOUS CT
    Automated Segmentation of CT-guided Ablation Margins in Colorectal Liver Metastases: How We Move Forward to a Standardization of Ablation Zone Assessment.
    Radiology. 2023 Jan 31:223276. doi: 10.1148/radiol.223276.
    PubMed    
    
    
    
76. LIN YM, Paolucci I, O'Connor CS, Anderson BM, et al
    Ablative Margins of Colorectal Liver Metastases Using Deformable CT Image Registration and Autosegmentation.
    Radiology. 2023 Jan 31:221373. doi: 10.1148/radiol.221373.
    PubMed     Abstract available
    
    
    
77. KIM H
    The Feasibility of Abbreviated MRI for Active Surveillance of Hepatocellular Carcinoma.
    Radiology. 2023 Jan 24:223113. doi: 10.1148/radiol.223113.
    PubMed    
    
    
    
78. YOKOO T, Masaki N, Parikh ND, Lane BF, et al
    Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma.
    Radiology. 2023 Jan 24:220917. doi: 10.1148/radiol.220917.
    PubMed     Abstract available
    
    
    
79. LEE S, Kim YY, Shin J, Son WJ, et al
    Percentages of Hepatocellular Carcinoma in LI-RADS Categories with CT and MRI: A Systematic Review and Meta-Analysis.
    Radiology. 2023 Jan 10:220646. doi: 10.1148/radiol.220646.
    PubMed     Abstract available
    
    
    
80. RONOT M
    Is MRI Better than CT for the LI-RADS?
    Radiology. 2023 Jan 10:222755. doi: 10.1148/radiol.222755.
    PubMed    
    
    
    
81. SIDHU PS, Fang C
    US-based Hepatic Fat Quantification: An Emerging Technique and Game Changer?
    Radiology. 2023 Jan 3:223002. doi: 10.1148/radiol.223002.
    PubMed    
    
    
    
82. JEON SK, Lee JM, Joo I, Yoon JH, et al
    Two-dimensional Convolutional Neural Network Using Quantitative US for Noninvasive Assessment of Hepatic Steatosis in NAFLD.
    Radiology. 2023 Jan 3:221510. doi: 10.1148/radiol.221510.
    PubMed     Abstract available
    
    
    
83. FUJITA S, Sano K, Cruz G, Fukumura Y, et al
    MR Fingerprinting for Liver Tissue Characterization: A Histopathologic Correlation Study.
    Radiology. 2023;306:150-159.
    PubMed     Abstract available
    
    
    December 2022
84. YOON JH, Kim H
    CT Radiomics in Oncology: Insights into the Tumor Microenvironment of Hepatocellular Carcinoma.
    Radiology. 2022 Dec 13:222988. doi: 10.1148/radiol.222988.
    PubMed    
    
    
    
85. FENG Z, Li H, Liu Q, Duan J, et al
    CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma.
    Radiology. 2022 Dec 13:221291. doi: 10.1148/radiol.221291.
    PubMed     Abstract available
    
    
    
86. SENDUR HN, Cerit MN
    Reliable Assessment of US Performance for Liver Fat Quantification.
    Radiology. 2022;305:E70.
    PubMed    
    
    
    
87. WU W, Jing X, Xue GQ, Zhu XL, et al
    A Multicenter Randomized Controlled Study of Contrast-enhanced US versus US-guided Biopsy of Focal Liver Lesions.
    Radiology. 2022;305:721-728.
    PubMed     Abstract available
    
    
    
88. DUAN L, Zhang B, Zheng X
    Restratification of Advanced Hepatocellular Carcinoma to Identify Patients Sensitive to Transarterial Chemoembolization.
    Radiology. 2022;305:E73.
    PubMed    
    
    
    November 2022
89. ZHANG W, Huang C, Yin T, Miao X, et al
    Ultrasensitive US Microvessel Imaging of Hepatic Microcirculation in the Cirrhotic Rat Liver.
    Radiology. 2022 Nov 22:220739. doi: 10.1148/radiol.220739.
    PubMed     Abstract available
    
    
    
90. FETZER DT
    US Microvessel Imaging of Rat Liver Microcirculation: Opportunities and Challenges for Human Imaging.
    Radiology. 2022 Nov 22:222735. doi: 10.1148/radiol.222735.
    PubMed    
    
    
    
91. FETZER DT, Rosado-Mendez IM, Wang M, Robbin ML, et al
    Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization.
    Radiology. 2022;305:265-276.
    PubMed     Abstract available
    
    
    
92. YOON JH
    A Placebo Effect on MRI Proton Density Fat Fraction in Nonalcoholic Steatohepatitis Trials.
    Radiology. 2022 Nov 1:222295. doi: 10.1148/radiol.222295.
    PubMed    
    
    
    
93. NEDRUD MA, Chaudhry M, Middleton MS, Moylan CA, et al
    MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical Trials.
    Radiology. 2022 Nov 1:220743. doi: 10.1148/radiol.220743.
    PubMed     Abstract available
    
    
    October 2022
94. WEIJERS G, Munsterman ID, Thijssen JM, Kuppeveld H, et al
    Noninvasive Staging of Hepatic Steatosis Using Calibrated 2D US with Liver Biopsy as the Reference Standard.
    Radiology. 2022 Oct 18:220104. doi: 10.1148/radiol.220104.
    PubMed     Abstract available
    
    
    
95. WEAR KA, Han A, Rubin JM, Gao J, et al
    US Backscatter for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.
    Radiology. 2022 Oct 18:220606. doi: 10.1148/radiol.220606.
    PubMed     Abstract available
    
    
    
96. KITAO A, Matsui O, Zhang Y, Ogi T, et al
    Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
    Radiology. 2022 Oct 11:220531. doi: 10.1148/radiol.220531.
    PubMed     Abstract available
    
    
    
97. HSIEH SS, Cook DA, Inoue A, Gong H, et al
    Understanding Reader Variability: A 25-Radiologist Study on Liver Metastasis Detection at CT.
    Radiology. 2022 Oct 4:220266. doi: 10.1148/radiol.220266.
    PubMed     Abstract available
    
    
    
98. EMMONS EC, Bishay S, Du L, Krebs H, et al
    Survival and Toxicities after (90)Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry.
    Radiology. 2022;305:228-236.
    PubMed     Abstract available
    
    
    September 2022
99. DUAN L, Zhang B, Zheng X
    Restratification of Advanced Hepatocellular Carcinoma to Identify Patients Sensitive to Transarterial Chemoembolization.
    Radiology. 2022 Sep 27:221149. doi: 10.1148/radiol.221149.
    PubMed    
    
    
    
100. GHELFI J, Decaens T, Macek Jilkova Z
     Rat Model of Hepatocellular Carcinoma for Better Understanding Immune Effects of Transarterial Chemoembolization.
     Radiology. 2022 Sep 6:220179. doi: 10.1148/radiol.220179.
     PubMed    
     
     
     
101. VALENCIA SA, Romero JA
     Limitations of a Multiparametric US Score for NASH Prediction.
     Radiology. 2022;304:E50.
     PubMed    
     
     
     August 2022
102. XIE J, Wei X
     Cirrhosis-related Spontaneous Mesocaval Shunt.
     Radiology. 2022 Aug 23:220564. doi: 10.1148/radiol.220564.
     PubMed     Abstract available
     
     
     
103. KWAG M, Choi SH, Choi SJ, Byun JH, et al
     Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI.
     Radiology. 2022 Aug 16:220659. doi: 10.1148/radiol.220659.
     PubMed     Abstract available
     
     
     
104. DEIPOLYI AR, Johnson CB, Riedl CC, Kunin H, et al
     Prospective Evaluation of Immune Activation Associated with Response to Radioembolization Assessed with PET/CT in Women with Breast Cancer Liver Metastasis.
     Radiology. 2022 Aug 16:220158. doi: 10.1148/radiol.220158.
     PubMed     Abstract available
     
     
     
105. CHOI SJ, Lee SS, Jung KH, Lee JB, et al
     Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT.
     Radiology. 2022 Aug 9:220536. doi: 10.1148/radiol.220536.
     PubMed     Abstract available
     
     
     
106. LUQUE-CABAL M, Alvarez-Guisasola V, Rizzo-Raza S, Sales-Fernandez C, et al
     Case 304: Porphyria Cutanea Tarda.
     Radiology. 2022;304:488-492.
     PubMed     Abstract available
     
     
     
107. TORKIAN P, Akhlaghpoor S
     Considerations Regarding Image-guided Treatment of Liver Hemangioma.
     Radiology. 2022;304:E45.
     PubMed    
     
     
     
108. YAN Y
     Three-dimensional MR Elastography in Distinguishing Necroinflammation from Liver Fibrosis.
     Radiology. 2022;304:E43.
     PubMed    
     
     
     
109. BARR RG
     US-targeted Microbubbles to Assess Liver Fibrosis.
     Radiology. 2022;304:483-484.
     PubMed    
     
     
     July 2022
110. DUBINSKY TJ
     Evaluating Hepatic Steatosis with MRI as the Reference Standard: Different Performances of Three US Machines.
     Radiology. 2022 Jul 12:221177. doi: 10.1148/radiol.221177.
     PubMed    
     
     
     
111. CASSINOTTO C, Jacq T, Anselme S, Ursic-Bedoya J, et al
     Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines.
     Radiology. 2022 Jul 12:212846. doi: 10.1148/radiol.212846.
     PubMed     Abstract available
     
     
     June 2022
112. JANG JK, Lee ES, Seo JW, Kim YR, et al
     Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study.
     Radiology. 2022 Jun 21:220220. doi: 10.1148/radiol.220220.
     PubMed     Abstract available
     
     
     
113. GAO RZ, Sun WB, Gao J
     Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: Is It a Promising Treatment for Giant Liver Hemangioma?
     Radiology. 2022;303:E39.
     PubMed    
     
     
     
114. RONOT M
     Performance of LI-RADS for the Noninvasive Diagnosis of HCC: Pathology Should Not Be the Only Acceptable Reference.
     Radiology. 2022;303:546-547.
     PubMed    
     
     
     May 2022
115. KHANNA G, Alazraki AL
     Quantitative US versus Quantitative MRI in the Assessment of Pediatric Chronic Liver Disease.
     Radiology. 2022 May 24:221066. doi: 10.1148/radiol.221066.
     PubMed    
     
     
     
116. ALVES VPV, Dillman JR, Tkach JA, Bennett PS, et al
     Comparison of Quantitative Liver US and MRI in Patients with Liver Disease.
     Radiology. 2022 May 24:212995. doi: 10.1148/radiol.212995.
     PubMed     Abstract available
     
     
     
117. RAMAN AG, Jones C, Weiss CR
     Machine Learning for Hepatocellular Carcinoma Segmentation at MRI: Radiology In Training.
     Radiology. 2022 May 10:212386. doi: 10.1148/radiol.212386.
     PubMed     Abstract available
     
     
     
118. MIAO X, Sha T, Zhang W, Zhou H, et al
     Liver Fibrosis Assessment by Viewing Sinusoidal Capillarization: US Molecular Imaging versus Two-dimensional Shear-Wave Elastography in Rats.
     Radiology. 2022 May 3:212325. doi: 10.1148/radiol.212325.
     PubMed     Abstract available
     
     
     April 2022
119. BORDE T, Nezami N, Gaupp FL, Savic LJ, et al
     Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI.
     Radiology. 2022 Apr 12:212426. doi: 10.1148/radiol.212426.
     PubMed     Abstract available
     
     
     
120. WHITE SB
     The Immune Response: A New Frontier in Interventional Oncology.
     Radiology. 2022;303:229-230.
     PubMed    
     
     
     
121. ATRI M, Jang HJ, Kim TK, Khalili K, et al
     Contrast-enhanced US of the Liver and Kidney: A Problem-solving Modality.
     Radiology. 2022;303:11-25.
     PubMed     Abstract available
     
     
     
122. KENNEDY P, Marron TU, Taouli B
     Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?
     Radiology. 2022;303:226-228.
     PubMed    
     
     
     March 2022
123. ITO K
     US-derived Fat Fraction Screening of Hepatic Steatosis.
     Radiology. 2022 Mar 29:213052. doi: 10.1148/radiol.213052.
     PubMed    
     
     
     
124. JUNG J, Han A, Madamba E, Bettencourt R, et al
     Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
     Radiology. 2022 Mar 29:211131. doi: 10.1148/radiol.211131.
     PubMed     Abstract available
     
     
     
125. LEE JT
     Sarcopenia at Abdominal CT in Patients with Cirrhosis.
     Radiology. 2022 Mar 15:220191. doi: 10.1148/radiol.220191.
     PubMed    
     
     
     
126. ZAFAR F, Lubert AM, Trout AT, Katz DA, et al
     Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation.
     Radiology. 2022 Mar 15:211037. doi: 10.1148/radiol.211037.
     PubMed     Abstract available
     
     
     
127. LIU J, Ma J, Yang C, Chen M, et al
     Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.
     Radiology. 2022 Mar 15:211172. doi: 10.1148/radiol.211172.
     PubMed     Abstract available
     
     
     
128. DHONDT E, Lambert B, Hermie L, Huyck L, et al
     (90)Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial.
     Radiology. 2022 Mar 8:211806. doi: 10.1148/radiol.211806.
     PubMed     Abstract available
     
     
     
129. VAN DER POL CB, McInnes MDF, Salameh JP, Chernyak V, et al
     Impact of Reference Standard on CT, MRI, and Contrast-enhanced US LI-RADS Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
     Radiology. 2022 Mar 1:212340. doi: 10.1148/radiol.212340.
     PubMed     Abstract available
     
     
     
130. DUAN L, Zhang BH, Zheng XH
     No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma.
     Radiology. 2022 Mar 1:211994. doi: 10.1148/radiol.211994.
     PubMed    
     
     
     February 2022
131. CHUNG JW
     Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of New Systemic Agents.
     Radiology. 2022 Feb 1:212826. doi: 10.1148/radiol.212826.
     PubMed    
     
     
     
132. ZHENG K, Zhu X, Fu S, Cao G, et al
     Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.
     Radiology. 2022 Feb 1:211545. doi: 10.1148/radiol.211545.
     PubMed     Abstract available
     
     
     January 2022
133. FERRAIOLI G, Kumar V, Ozturk A, Nam K, et al
     US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.
     Radiology. 2022 Jan 25:210736. doi: 10.1148/radiol.210736.
     PubMed     Abstract available
     
     
     
134. TISCHFIELD DJ, Gurevich A, Johnson O, Gatmaytan I, et al
     Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat Model.
     Radiology. 2022 Jan 11:211028. doi: 10.1148/radiol.211028.
     PubMed     Abstract available
     
     
     
135. JENSEN CT, Gupta S, Saleh MM, Liu X, et al
     Reduced-Dose Deep Learning Reconstruction for Abdominal CT of Liver Metastases.
     Radiology. 2022 Jan 11:211838. doi: 10.1148/radiol.211838.
     PubMed     Abstract available
     
     
     December 2021
136. LOCKHART ME
     NASH Diagnosis Made Better but Maybe Not Yet Easier.
     Radiology. 2021;301:635-636.
     PubMed    
     
     
     
137. SUGIMOTO K, Lee DH, Lee JY, Yu SJ, et al
     Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study.
     Radiology. 2021;301:625-634.
     PubMed     Abstract available
     
     
     November 2021
138. VAN DER POL CB, McInnes MDF, Salameh JP, Levis B, et al
     CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
     Radiology. 2021 Nov 16:211244. doi: 10.1148/radiol.2021211244.
     PubMed     Abstract available
     
     
     
139. MARTI-AGUADO D, Jimenez-Pastor A, Alberich-Bayarri A, Rodriguez-Ortega A, et al
     Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
     Radiology. 2021 Nov 16:211027. doi: 10.1148/radiol.2021211027.
     PubMed     Abstract available
     
     
     
140. DING PX, Lee EW
     Spontaneous Portosystemic Shunt with Budd-Chiari Syndrome.
     Radiology. 2021;301:282.
     PubMed     Abstract available
     
     
     
141. AYOOBI YAZDI N, Mehrabinejad MM, Dashti H, Pourghorban R, et al
     Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma.
     Radiology. 2021;301:464-471.
     PubMed     Abstract available
     
     
     October 2021
142. PEREZ AA, Noe-Kim V, Lubner MG, Graffy PM, et al
     Deep Learning CT-based Quantitative Visualization Tool for Liver Volume Estimation: Defining Normal and Hepatomegaly.
     Radiology. 2021 Oct 26:210531. doi: 10.1148/radiol.2021210531.
     PubMed     Abstract available
     
     
     
143. REEDER SB
     Emergence of 3D MR Elastography-based Quantitative Markers for Diffuse Liver Disease.
     Radiology. 2021;301:163-165.
     PubMed    
     
     
     
144. SOULEN MC, Garcia-Monaco R
     Closing the Gap in Curative Ablation of Liver Cancer.
     Radiology. 2021;301:237-238.
     PubMed    
     
     
     September 2021
145. MORRELL GR
     Detection of Tumor Thrombus in Hepatocellular Carcinoma.
     Radiology. 2021 Sep 28:211984. doi: 10.1148/radiol.2021211984.
     PubMed    
     
     
     
146. BAE JS, Lee JM, Jeon SK, Yoo J, et al
     LI-RADS Tumor in Vein at CT and Hepatobiliary MRI.
     Radiology. 2021 Sep 28:210215. doi: 10.1148/radiol.2021210215.
     PubMed     Abstract available
     
     
     
147. YU MM, Tang XL, Jin H, Yang S, et al
     Coronary CT Angiography in Asymptomatic Adults with Hepatic Steatosis.
     Radiology. 2021 Sep 21:210355. doi: 10.1148/radiol.2021210355.
     PubMed     Abstract available
     
     
     
148. STAREKOVA J, Hernando D, Pickhardt PJ, Reeder SB, et al
     Quantification of Liver Fat Content with CT and MRI: State of the Art.
     Radiology. 2021 Sep 21:204288. doi: 10.1148/radiol.2021204288.
     PubMed     Abstract available
     
     
     August 2021
149. ZHANG T, Zhang G, Deng X, Zeng J, et al
     APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
     Radiology. 2021 Aug 24:204700. doi: 10.1148/radiol.2021204700.
     PubMed     Abstract available
     
     
     
150. SHI Y, Qi YF, Lan GY, Wu Q, et al
     Three-dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C.
     Radiology. 2021 Aug 10:202804. doi: 10.1148/radiol.2021202804.
     PubMed     Abstract available
     
     
     July 2021
151. LEE DH, Lee MW, Kim PN, Lee YJ, et al
     Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
     Radiology. 2021 Jul 27:210309. doi: 10.1148/radiol.2021210309.
     PubMed     Abstract available
     
     
     
152. HE KS, Fernando R, Cabrera T, Valenti D, et al
     Hepatic Hilar Nerve Block for Hepatic Interventions: Anatomy, Technique, and Initial Clinical Experience in Thermal Ablation of Liver Tumors.
     Radiology. 2021 Jul 13:203410. doi: 10.1148/radiol.2021203410.
     PubMed     Abstract available
     
     
     
153. KRINSKY G, Shanbhogue K
     Proliferative versus Nonproliferative Hepatocellular Carcinoma: Clinical and Imaging Implications.
     Radiology. 2021 Jul 6:211316. doi: 10.1148/radiol.2021211316.
     PubMed    
     
     
     
154. KANG HJ, Kim H, Lee DH, Hur BY, et al
     Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
     Radiology. 2021 Jul 6:204352. doi: 10.1148/radiol.2021204352.
     PubMed     Abstract available
     
     
     June 2021
155. JIANG H, Chen HC, Lafata KJ, Bashir MR, et al
     Week 4 Liver Fat Reduction on MRI as an Early Predictor of Treatment Response in Participants with Nonalcoholic Steatohepatitis.
     Radiology. 2021 Jun 1:204325. doi: 10.1148/radiol.2021204325.
     PubMed     Abstract available
     
     
     
156. DU J, Bydder GM
     Brain Atrophy Is a Better Biomarker than Susceptibility for Evaluating Clinical Severity in Wilson Disease.
     Radiology. 2021;299:673-674.
     PubMed    
     
     
     May 2021
157. BAI XM, Cui M, Yang W, Wang H, et al
     The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
     Radiology. 2021 May 18:200153. doi: 10.1148/radiol.2021200153.
     PubMed     Abstract available
     
     
     
158. YOON JH, Kim H
     CT Characterization of Aggressive Macrotrabecular-Massive Hepatocellular Carcinoma: A Step Forward to Personalized Medicine.
     Radiology. 2021 May 11:210379. doi: 10.1148/radiol.2021210379.
     PubMed    
     
     
     
159. FENG Z, Li H, Zhao H, Jiang Y, et al
     Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
     Radiology. 2021 May 11:203614. doi: 10.1148/radiol.2021203614.
     PubMed     Abstract available
     
     
     
160. MEIJERINK MR, Ruarus AH, Vroomen LGPH, Puijk RS, et al
     Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
     Radiology. 2021;299:470-480.
     PubMed     Abstract available
     
     
     April 2021
161. PAISANT A, Gillard M, Oberti F, Roux M, et al
     Validation of a Diagnostic Algorithm for Hepatocellular Carcinoma at Gadoxetic Acid-enhanced MRI.
     Radiology. 2021 Apr 27:204529. doi: 10.1148/radiol.2021204529.
     PubMed     Abstract available
     
     
     
162. LV J, Xu Y, Xu L, Nie L, et al
     Quantitative Functional Evaluation of Liver Fibrosis in Mice with Dynamic Contrast-enhanced Photoacoustic Imaging.
     Radiology. 2021 Apr 27:204134. doi: 10.1148/radiol.2021204134.
     PubMed     Abstract available
     
     
     
163. LUZ JHM, Veloso Gomes F, Costa NV, Vasco I, et al
     BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils.
     Radiology. 2021 Apr 6:204055. doi: 10.1148/radiol.2021204055.
     PubMed     Abstract available
     
     
     March 2021
164. DUSEK P, Lescinskij A, Ruzicka F, Acosta-Cabronero J, et al
     Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
     Radiology. 2021 Mar 23:202846. doi: 10.1148/radiol.2021202846.
     PubMed     Abstract available
     
     
     
165. BASHIR MR, Mendiratta-Lala M
     CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.
     Radiology. 2021 Mar 2:210049. doi: 10.1148/radiol.2021210049.
     PubMed    
     
     
     February 2021
166. REEDER SB
     Portosystemic Shunts: Should We Pay Closer Attention with Cross-Sectional Imaging?
     Radiology. 2021 Feb 2:204282. doi: 10.1148/radiol.2021204282.
     PubMed    
     
     
     January 2021
167. HU HH, Yokoo T, Bashir MR, Sirlin CB, et al
     Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study.
     Radiology. 2021 Jan 19:202912. doi: 10.1148/radiol.2021202912.
     PubMed     Abstract available
     
     
     
168. CHANDARANA H, Shanbhogue K
     Noninvasive Staging of Liver Fibrosis with Dual-Energy CT: Close but No Cigar.
     Radiology. 2021 Jan 5:204315. doi: 10.1148/radiol.2021204315.
     PubMed    
     
     
     
169. MARRI UK, Das P, Shalimar, Kalaivani M, et al
     Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings.
     Radiology. 2021 Jan 5:202232. doi: 10.1148/radiol.2021202232.
     PubMed     Abstract available
     
     
     
170. KIESSLING F
     US Microbubbles as Smart Sensors of Portal Venous Pressure.
     Radiology. 2021;298:112-113.
     PubMed    
     
     
     
171. HAN K, Kim JH, Yang SG, Park SH, et al
     A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
     Radiology. 2021;298:212-218.
     PubMed     Abstract available
     
     
     
172. KANG TW, Jeong WK, Kim YY, Min JH, et al
     Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia.
     Radiology. 2021;298:82-90.
     PubMed     Abstract available
     
     
     November 2020
173. SOULEN MC, Sofocleous CT
     Achieving Curative Ablation Outcomes: It Is All about the Imaging.
     Radiology. 2020 Nov 10:203930. doi: 10.1148/radiol.2020203930.
     PubMed    
     
     
     October 2020
174. FETZER DT
     Recent Advances in US Vascular Imaging: Highlighting an Important Use Case.
     Radiology. 2020 Oct 27:203830. doi: 10.1148/radiol.2020203830.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.